Baolingbao Biology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	283.51	273.98	254.95	242.74	375.95	585.44
Trading Asset Securities	2	2.8	-	-	-	106.67
Cash & Short-Term Investments	285.51	276.78	254.95	242.74	375.95	692.11
Cash Growth	1.24%	8.56%	5.03%	-35.43%	-45.68%	42.63%
Accounts Receivable	331.82	271.64	245.79	241.99	238.48	284.29
Other Receivables	16.96	20.84	8.06	19.25	12.32	19
Receivables	348.78	292.48	253.85	261.24	250.8	303.29
Inventory	324.99	321.91	288.71	278.58	335.39	285.09
Prepaid Expenses	-	-	-	-	-	0.76
Other Current Assets	61.43	23.14	12.71	3.31	33.64	33.63
Total Current Assets	1,021	914.3	810.22	785.87	995.78	1,315
Property, Plant & Equipment	1,505	1,471	1,454	1,433	1,532	1,286
Long-Term Investments	216.49	210.47	246.92	286.16	323.53	268.14
Other Intangible Assets	113.78	114.11	117.5	121.28	125.07	129.27
Long-Term Deferred Tax Assets	17.19	15.89	10.31	5.58	4.16	3.32
Long-Term Deferred Charges	29.01	26.13	22.38	20.42	18.68	12.14
Other Long-Term Assets	26.31	29.14	12.21	6.91	6.65	14.89
Total Assets	2,928	2,781	2,674	2,659	3,006	3,029
Accounts Payable	228.12	227.21	213.11	237.56	314.16	634.38
Accrued Expenses	24.42	41.71	39.12	32.84	38.54	42.22
Short-Term Debt	205.06	102.6	260.19	209.81	244.17	369.18
Current Portion of Long-Term Debt	11.56	9.91	9.51	42	85.9	0.5
Current Portion of Leases	-	2.05	1.15	3.38	5.07	4.43
Current Income Taxes Payable	30.09	21.64	5.64	2.66	4.83	10.87
Current Unearned Revenue	15.97	22.67	33.45	20.3	42	29.35
Other Current Liabilities	54.51	56.95	13.94	27.92	24.79	28.92
Total Current Liabilities	569.73	484.74	576.1	576.47	759.46	1,120
Long-Term Debt	10.79	10.79	10.79	48.69	178.39	30.32
Long-Term Leases	1.02	1.19	1.17	0.25	3.07	7.45
Long-Term Unearned Revenue	43.15	50.19	43.66	49.14	60.07	58.11
Long-Term Deferred Tax Liabilities	0.88	0.9	0.71	0.85	0.8	0.04
Total Liabilities	625.57	547.81	632.44	675.41	1,002	1,216
Common Stock	380.57	380.57	369.77	370.77	371.81	371.91
Additional Paid-In Capital	886.23	873.24	812.45	818.51	830.64	821.56
Retained Earnings	994.66	940.52	812.67	743.89	719.52	608.66
Treasury Stock	-42.88	-42.88	-	-7.06	-14.4	-18.7
Comprehensive Income & Other	84.14	82.14	46.64	57.38	96.77	29.8
Total Common Equity	2,303	2,234	2,042	1,983	2,004	1,813
Shareholders' Equity	2,303	2,234	2,042	1,983	2,004	1,813
Total Liabilities & Equity	2,928	2,781	2,674	2,659	3,006	3,029
Total Debt	228.43	126.54	282.81	304.13	516.6	411.88
Net Cash (Debt)	57.07	150.24	-27.86	-61.39	-140.65	280.23
Net Cash Growth	-	-	-	-	-	17.19%
Net Cash Per Share	0.15	0.41	-0.08	-0.17	-0.38	0.75
Filing Date Shares Outstanding	380.57	380.57	369.77	370.77	371.81	371.91
Total Common Shares Outstanding	380.57	380.57	369.77	370.77	371.81	371.91
Working Capital	450.98	429.56	234.12	209.39	236.32	195.05
Book Value Per Share	6.05	5.87	5.52	5.35	5.39	4.88
Tangible Book Value	2,189	2,119	1,924	1,862	1,879	1,684
Tangible Book Value Per Share	5.75	5.57	5.20	5.02	5.05	4.53
Buildings	-	780.87	771.66	770.06	-	-
Machinery	-	1,544	1,476	1,559	-	-
Construction In Progress	-	131.36	115.74	2.57	40.48	52.85